Oscar Health, Inc. (OSCR)
NYSE · Hospital & Medical Service Plans · Finance, insurance and real estate · CIK 1568651 · fiscal year ends in Dec
Closing price $30.49 on 28 Oct 2026; 52-week range $10.85 to $34.34.
Key figures
The last twelve months reported, with the latest price and balance sheet.
- Revenue, last twelve months
- $15.3B
- Revenue growth
- 42.8%
- Net income, last twelve months
- $550.7M
- Earnings per share
- $1.40
- Operating margin
- 4.1%
- Net margin
- 3.6%
- Free cash flow
- $4.4B
- Return on equity
- 26.8%
- Market value
- $10.2B
- Price to earnings
- 21.8x
- Cash
- $4.1B
- Debt
- $431.6M
- Debt to equity
- 0.21
Financial statements
Revenue, profit and cash flow by fiscal year, each year linked to its annual report.
| Fiscal year | Year end | Revenue | Operating income | Net income | EPS | Free cash flow | Filing |
|---|---|---|---|---|---|---|---|
| FY2025 | 31 Dec 2025 | $11.7B | -$396.4M | -$443.2M | -$1.69 | $1.1B | 10-K filed 13 Feb 2026 |
| FY2024 | 31 Dec 2024 | $9.2B | $57.3M | $25.4M | $0.10 | $950.3M | 10-K filed 20 Feb 2025 |
| FY2023 | 31 Dec 2023 | $5.9B | -$235.6M | -$270.7M | -$1.22 | -$297.7M | 10-K filed 15 Feb 2024 |
| FY2022 | 31 Dec 2022 | $4.0B | -$589.9M | -$606.3M | -$2.85 | $351.3M | 10-K filed 24 Feb 2023 |
| FY2021 | 31 Dec 2021 | $1.8B | -$544.5M | -$572.6M | -$3.20 | -$207.6M | 10-K filed 25 Feb 2022 |
By quarter
| Quarter | Quarter end | Revenue | Net income | EPS |
|---|---|---|---|---|
| Q2 FY2026 | 30 Jun 2026 | $4.9B | $361.8M | $1.10 |
| Q1 FY2026 | 31 Mar 2026 | $4.6B | $679.0M | $2.07 |
| Q4 FY2025 | 31 Dec 2025 | $2.8B | -$352.6M | -$1.24 |
| Q3 FY2025 | 30 Sep 2025 | $3.0B | -$137.4M | -$0.53 |
| Q2 FY2025 | 30 Jun 2025 | $2.9B | -$228.4M | -$0.89 |
| Q1 FY2025 | 31 Mar 2025 | $3.0B | $275.3M | $0.92 |
| Q4 FY2024 | 31 Dec 2024 | $2.4B | -$153.5M | -$0.62 |
| Q3 FY2024 | 30 Sep 2024 | $2.4B | -$54.6M | -$0.22 |
What the company said with its results
From the second quarter of 2026 results, filed 6 August 2026.
- Record first-half profitability; guidance raised. Management said the company delivered record profitability in the first half and is raising its full-year 2026 guidance.
- Earnings from operations turned positive. Earnings from operations were $388.6 million in the second quarter, against a loss of $230.5 million a year earlier.
- Diluted EPS of $1.10. Net income attributable to Oscar was $361.8 million, or $1.10 diluted EPS, against a diluted loss of $(0.89) a year earlier.
- Adjusted EBITDA reached $415.3 million. Adjusted EBITDA was $415.3 million, against a loss of $199.4 million in the second quarter of 2025.
- Total revenue near $4.9 billion. Total revenue was about $4.9 billion, against $2.9 billion a year earlier, on higher membership and rate increases, partly offset by a higher net risk adjustment accrual.
- MLR fell to 79.2%. Medical loss ratio was 79.2% against 91.1% a year earlier, with management citing disciplined pricing and favorable prior period reserve development.
- SG&A expense ratio fell to 14.2%. SG&A expense ratio was 14.2% against 18.7%, which management attributed to expense management, fixed cost leverage and lower risk adjustment as a share of premium.
- $164 million favorable reserve development. Management attributed the lower MLR to disciplined pricing and $164 million of favorable prior period reserve development in the quarter.
- Six-month MLR and SG&A ratios. For the first half, MLR was 75.0% against 83.0% and the SG&A expense ratio was 14.7% against 17.2%.
- Risk adjustment transfers rose. Risk adjustment transfers were $871.5 million in the quarter against $692.2 million a year earlier, and $2,314.3 million in the first half against $1,066.0 million.
- Q1 favorable development was $68 million. The first-quarter release reported $68 million of favorable development, against $31 million of unfavorable development a year earlier.
- Prior-year risk adjustment accrual change. The prior years change in net risk adjustment accrual was $(59,151) thousand in the first half of 2026, against $77,532 thousand in the first half of 2025.
- Effectuated membership at June 30. Effectuated individual and small group members were 2,963,002 at June 30, 2026, against 2,017,058 a year earlier and 3,174,489 at March 31, 2026.
- Workforce shifts cited for individual market. Management said more people are moving between full- and part-time jobs, gig work and retirement, a shift it expects AI to accelerate.
Company events
The newest 8-K filings of 62 held.
| Filed | Form | Event | Items |
|---|---|---|---|
| 16 Sep 2026 | 8-K | Investor update | 7.01 |
| 6 Aug 2026 | 8-K | Results | 2.02, 9.01 |
| 9 Jun 2026 | 8-K | Shareholder vote | 5.07 |
| 8 Jun 2026 | 8-K | Investor update | 7.01 |
| 2 Jun 2026 | 8-K | Leadership change | 5.02 |
| 6 May 2026 | 8-K | Results | 2.02, 9.01 |
| 21 Apr 2026 | 8-K | Investor update | 7.01, 9.01 |
| 2 Mar 2026 | 8-K | Investor update | 7.01 |
| 10 Feb 2026 | 8-K | Results, Material agreement, New debt | 1.01, 2.02, 2.03, 9.01 |
| 29 Dec 2025 | 8-K | Leadership change | 5.02 |
| 6 Nov 2025 | 8-K | Results, Other events | 2.02, 8.01, 9.01 |
| 18 Sep 2025 | 8-K | Material agreement, New debt, Share sale | 1.01, 2.03, 3.02, 9.01 |
Every filing
The newest filings with the SEC of 137 held.
| Filed | Form | Period |
|---|---|---|
| 16 Sep 2026 | 8-K | 16 Sep 2026 |
| 7 Aug 2026 | 10-Q | 30 Jun 2026 |
| 6 Aug 2026 | 8-K | 6 Aug 2026 |
| 9 Jun 2026 | 8-K | 4 Jun 2026 |
| 8 Jun 2026 | 8-K | 8 Jun 2026 |
| 2 Jun 2026 | 8-K | 29 May 2026 |
| 7 May 2026 | 10-Q | 31 Mar 2026 |
| 6 May 2026 | 8-K | 6 May 2026 |
| 22 Apr 2026 | ARS | 31 Dec 2025 |
| 22 Apr 2026 | DEFA14A | – |
| 22 Apr 2026 | DEF 14A | 4 Jun 2026 |
| 21 Apr 2026 | 8-K | 21 Apr 2026 |
Insider trades
Form 4 trades by officers, directors and 10% owners, last 12 months.
| Traded | Insider | Type | Shares | Price | Value | Held after | Form 4 |
|---|---|---|---|---|---|---|---|
| 8 Oct 2026 | Plouffe David, Director | Took pay in stock | 641 | $33.10 | $21.2K | – | 13 Oct 2026 |
| 8 Oct 2026 | Sankaran Sid, Director | Took pay in stock | 1,472 | $33.10 | $48.7K | – | 13 Oct 2026 |
| 8 Oct 2026 | Gassen William, Director | Took pay in stock | 698 | $33.10 | $23.1K | – | 13 Oct 2026 |
| 18 Sep 2026 | Wittman Vanessa Ames, Director | Sale under a trading plan | 25,000 | $32.24 | $806.0K | 112,121 | 22 Sep 2026 |
| 3 Sep 2026 | Liang Janet, President, Oscar Insurance | Sale under a trading plan | 10,360 | $31.45 | $325.8K | 248,697 | 8 Sep 2026 |
| 3 Sep 2026 | Baltrus Victoria, Chief Accounting Officer | Sale under a trading plan | 958 | $31.45 | $30.1K | 213,631 | 8 Sep 2026 |
| 3 Sep 2026 | Blackley Richard Scott, Chief Financial Officer | Sale under a trading plan | 28,869 | $31.45 | $907.9K | 1,046,108 | 8 Sep 2026 |
| 3 Sep 2026 | Mcananey Adam, Chief Legal Officer | Sale under a trading plan | 9,092 | $31.45 | $285.9K | 209,004 | 8 Sep 2026 |
| 3 Sep 2026 | Schlosser Mario, Director | Sale under a trading plan | 31,422 | $31.45 | $988.2K | 449,444 | 8 Sep 2026 |
| 28 Aug 2026 | Schlosser Mario, Director | Sale outside a trading plan | 150,000 | $30.79 | $4.6M | 480,866 | 31 Aug 2026 |
| 27 Aug 2026 | Schlosser Mario, Director | Sale outside a trading plan | 600,000 | $30.34 | $18.2M | 480,866 | 31 Aug 2026 |
| 18 Aug 2026 | Blackley Richard Scott, Chief Financial Officer | Sale outside a trading plan | 18,750 | $31.74 | $595.1K | 56,250 | 20 Aug 2026 |
Planned insider sales
Form 144 notices, filed when the sell order goes to the broker.
| Filed | Seller | Shares | Value | Planned sale |
|---|---|---|---|---|
| 18 Sep 2026 | WITTMAN VANESSA AMES, Officer | 25,000 | $806.0K | 18 Sep 2026 |
| 3 Sep 2026 | McAnaney Adam, Officer | 9,092 | $285.9K | 3 Sep 2026 |
| 3 Sep 2026 | Liang Janet, Officer | 10,360 | $325.8K | 3 Sep 2026 |
| 3 Sep 2026 | Blackley Richard Scott, Officer | 28,869 | $908.0K | 3 Sep 2026 |
| 3 Sep 2026 | Schlosser Mario, Officer, Director | 31,422 | $988.2K | 3 Sep 2026 |
| 28 Aug 2026 | Schlosser Mario, Officer, Director | 150,000 | $4.6M | 28 Aug 2026 |
| 27 Aug 2026 | Schlosser Mario, Officer, Director | 600,000 | $18.2M | 27 Aug 2026 |
| 20 Aug 2026 | JEFFERY H. BOYD, Former Affiliate | 288,514 | $9.6M | 20 Aug 2026 |
| 18 Aug 2026 | Richard Scott Blackley, Officer - CFO | 18,750 | $614.3K | 18 Aug 2026 |
| 13 Aug 2026 | JEFFERY H. BOYD, Former Affiliate | 288,513 | $8.7M | 13 Aug 2026 |
Large holders
Schedule 13D and 13G filings by holders of more than 5% of the voting shares.
| Filed | Holder | Schedule | Stake | Shares |
|---|---|---|---|---|
| 18 Sep 2026 | Thrive Capital Partners II, L.P. | 13D amended | 12.1% | 37.5M |
| 27 Mar 2026 | The Vanguard Group | 13G amended | 0% | 0 |
| 17 Feb 2026 | Marc Stad | 13G amended | 0.3% | 657.4K |
| 14 Nov 2025 | T. Rowe Price Investment Management, Inc. | 13G amended | 3.7% | 8.3M |
| 13 Nov 2025 | Deerfield Mgmt, L.P. | 13G amended | 0% | 0 |
Short interest
Shares sold short and not yet bought back, on each FINRA settlement date.
| Settlement | Shares short | Change | Days to cover |
|---|---|---|---|
| 15 Oct 2026 | 18.3M | +11.2% | 3.73 |
| 30 Sep 2026 | 16.5M | -7.42% | 2.68 |
| 15 Sep 2026 | 17.8M | +8.59% | 3.65 |
| 31 Aug 2026 | 16.4M | -0.45% | 3.47 |
| 14 Aug 2026 | 16.4M | -7.78% | 2.34 |
| 31 Jul 2026 | 17.8M | -8.94% | 4.08 |
| 15 Jul 2026 | 19.6M | +4.45% | 4.01 |
| 30 Jun 2026 | 18.7M | +7.31% | 2.74 |
Funds that hold it
From each fund's latest Form 13F.
455 funds held it at 30 Jun 2026: 252 added and 99 trimmed in the quarter. The largest:
| Fund | Shares | Value | Change in the quarter |
|---|---|---|---|
| BlackRock, Inc. | 20,587,428 | $587.2M | +3,277,889 |
| T. Rowe Price Investment Management, Inc. | 13,035,486 | $371.8M | +1,390,990 |
| D. E. Shaw & Co., Inc. | 12,643,617 | $360.6M | +7,158,332 |
| Vanguard Portfolio Management LLC | 11,029,424 | $314.6M | +483,576 |
| Vanguard Capital Management LLC | 10,579,437 | $301.7M | -198,190 |
| American Century Companies Inc. | 9,055,242 | $258.3M | +2,025,886 |
| Jane Street Group, LLC | 6,365,039 | $181.5M | +3,460,934 |
| Thrive Capital Management, LLC | 6,343,617 | $180.9M | 0 |
| Geode Capital Management, LLC | 5,819,186 | $166.0M | +786,931 |
| State Street Corp. | 5,801,351 | $165.5M | +538,979 |
Peers
Companies in the same industry.
- UnitedHealth Group Inc. (UNH): revenue $450.1B, market value $368.6B
- Elevance Health, Inc. (ELV): revenue $201.8B, market value $89.5B
- Cigna Group (CI): revenue $282.4B, market value $78.0B
- Humana Inc. (HUM): revenue $145.7B, market value $49.5B
- Centene Corp. (CNC): revenue $203.9B, market value $33.2B
- Molina Healthcare, Inc. (MOH): revenue $44.1B, market value $10.3B
- Alignment Healthcare, Inc. (ALHC): revenue $4.6B, market value $1.7B
- Trupanion, Inc. (TRUP): revenue $1.5B, market value $1.3B
What the company does
Oscar Health, Inc. sells health insurance plans under the Affordable Care Act (ACA) to individuals, families and employees. It also offers a technology platform to other healthcare companies. As of 31 December 2025 it had approximately 2.0 million effectuated members, meaning people who are actively enrolled and have either paid their premium or are within the grace period. It offered coverage in 18 states for the 2025 policy year and had approximately 2,305 employees.
How the business is organised
Oscar describes three parts: its insurance business, the +Oscar platform, and brokerage services and an enrollment platform. The insurance business runs on the company's own cloud-native technology platform. Through +Oscar, the company offers Campaign Builder, an engagement and recommendation platform for providers and payors. As of 31 December 2025 it served nearly 0.6 million client lives, in addition to the approximately 2.0 million Oscar members.
In 2025 the company acquired three early-stage businesses. Lucie, Inc. is a direct enrollment technology platform and, in the filing's words, one of only 11 CMS-approved solutions. IHC Specialty Benefits, Inc. is an individual market brokerage offering individual medical and supplemental health products across carriers in all 50 states. Healthinsurance.org, LLC is a consumer education website. The company says these support its strategy around Individual Coverage Health Reimbursement Arrangements (ICHRA).
What it sells
Oscar's health plans are sold in the individual market. Buyers include people using the Health Insurance Marketplaces, people buying off-exchange, and employees whose employers offer an ICHRA. Plans come in the five ACA metal categories: Catastrophic, Bronze, Silver, Gold and Platinum. They differ in monthly premium and in how medical costs are shared between Oscar and the member. Some products are aimed at particular needs, such as diabetes, asthma or menopause. Oscar has exclusive provider organization plans in most markets and HMO plans in select markets. State and federal regulators must approve its premium rates, and the company chooses each year whether to take part in a given individual market.
Who pays and how members enrol
The vast majority of revenue comes from health insurance premiums. For the year ended 31 December 2025, 93% of premiums were earned directly from the Centers for Medicare & Medicaid Services (CMS) through the advance premium tax credits program, and 7% came from members.
Members are acquired through brokers, directly through the Health Insurance Marketplaces, and directly through Oscar's digital platform. The company also works with ICHRA platform companies to enroll employees. The vast majority of members come through brokers, who typically use an enhanced direct enrollment platform. Oscar therefore competes partly through the commissions and bonuses it pays them.
Where it operates
Oscar offers coverage in 18 states for the 2025 policy year and has expanded to 20 states for 2026.
How it competes
Its main competitors in the individual market are plans from national carriers, regional carriers, Medicaid-focused insurers offering Health Insurance Marketplaces products, and local Blue Cross plans. The company says it competes on the range and prices of plans, provider network breadth and quality, benefits, service and member experience. Its model is to contract with selected health systems and other providers rather than all of them in an area. Contracts are set market by market and can use fee-for-service, value-based or capitation payment.
Technology, regulation and risk
Oscar built a single-threaded platform covering member and provider data, utilization management, claims, billing and benefits. It uses AI technologies for administrative automation, member personalization and digital self-service. It works with Amazon and Google for its information technology systems and runs its Amazon Web Services platform across multiple availability zones. It owns four registered trademarks in the United States and holds no patents.
The business is regulated at federal and state levels. The minimum medical loss ratio for the individual market set by the Department of Health and Human Services is 80%, and New York requires 82%. Insurers that fall short must pay rebates to members. CMS also runs a risk adjustment program that moves funds between plans based on member risk scores. Oscar uses quota share and excess of loss reinsurance for risk management and capital efficiency. It provides virtual care through Oscar Medical Group, which consists of five physician-owned professional corporations.
*From Oscar Health's annual report on Form 10-K for the year ended 31 December 2025. [The filing](https://www.sec.gov/Archives/edgar/data/1568651/000156865126000011/oscr-20251231.htm)*
From the company's 10-K.